Repligen Corp
(NAS:RGEN)
$
138.4
+12.01 (+9.5%)
Market Cap: 7.81 Bil
Enterprise Value: 7.71 Bil
PE Ratio: 153.78
PB Ratio: 3.71
GF Score: 83/100 Repligen Corp at Evercore ISI Healthcare Conference Transcript
Dec 03, 2025 / 06:20PM GMT
Release Date Price:
$166.52
(+0.91%)
Daniel Markowitz
Evercore Inc - Analyst
We're live? Great. Awesome. Thank you, everyone, for joining. For those of you who don't know me, I'm Daniel Markowitz. I cover the life science tools and diagnostics at medtech space here at Evercore ISI. Today we're joined by Repligen. We have with us CFO, Jason Garland; and from Investor Relations, Steven Chehames. So thank you both for joining.
Steven Chehames
Repligen Corp - Director - Investor Relations
Thanks for having us.
Jason Garland
Repligen Corp - Chief Financial Officer
Hi, everyone.
Questions & Answers
Daniel Markowitz;Jason Garland
Evercore Inc - Analyst;Repligen
Awesome. So lots to get into here. I would love to just start off on 3Q performance. So I think you guys delivered 18% organic growth, double-digit growth across every franchise. Can you just talk about some of the drivers of this performance? Were there any standout products or customer categories to call out?
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot